1 / 12

CERVICAL CANCER PREVENTION STRATEGIES

CERVICAL CANCER PREVENTION STRATEGIES. Z Mike Chirenje MD FRCOG Department of Obstetrics and Gynaecology University of Zimbabwe, Harare Zimbabwe chirenje@uz-ucsf.co.zw. Problem in Zimbabwean women:. Female cancers registered in 2002 by site: Cervix uteri (771) 25.9%

janet
Download Presentation

CERVICAL CANCER PREVENTION STRATEGIES

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CERVICAL CANCER PREVENTION STRATEGIES Z Mike Chirenje MD FRCOG Department of Obstetrics and Gynaecology University of Zimbabwe, Harare Zimbabwe chirenje@uz-ucsf.co.zw

  2. Problem in Zimbabwean women: Female cancers registered in 2002 by site: • Cervix uteri (771) 25.9% • Kaposi sarcoma (478) 16.1% • Breast (304) 10.2% • Ovary (74) 2.5% • Cervix corpus (40) 1.3% Zimbabwe cancer Registry (2006). • Therefore 1 in every 5 women diagnosed to have cancer had cervical cancer.

  3. Epidemiology and Treatment of Cervical Cancer : • Cervical cancer is often slow growing, with progressive generalised wasting for several months that creates difficult home care in low resources. • Family members complain about the unbearable smell that is socially embarrassing and impossible to eradicate (unresponsive to antibiotics).

  4. Cervical Cancer Prevention Primary (e.g. delayed intercourse) Secondary: = Pap smear =Visual Inspection with acetic acid (Chirenje et al Lancet 1999) = Lugol’s Iodine = HPV vaccination (Merck covers HPV types 6,11,16 and 18 and GSK covers types 16 and 18). HPV types 16 and 18 cause 70% of cervical cancer cases

More Related